We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our privacy policy and for us to access our cookies on your device.
Description:Sep.01 -- Charles Li, chief executive at Hong Kong Exchanges & Clearing Ltd., discusses the company’s interest in biotech companies and why these companies would list in Hong Kong. He speaks on “Bloomberg Daybreak: Asia” from the HKEX Biotech Summit in Hong Kong.
